Journal ArticleSci Transl Med · March 27, 2019
Traditional vascular grafts constructed from synthetic polymers or cadaveric human or animal tissues support the clinical need for readily available blood vessels, but often come with associated risks. Histopathological evaluation of these materials has sh ...
Full textLink to itemCite
Journal ArticleAm J Nephrol · 2019
BACKGROUND: Chronic hemodialysis requires a mode of vascular access through an arteriovenous fistula (AVF), a prosthetic arteriovenous graft (AVG), or a central venous catheter (CVC). AVF is recommended over AVG or CVC due to increased patency and decrease ...
Full textLink to itemCite
Journal ArticleScience Translational Medicine · January 1, 2019
In the Research Article "Bioengineered human acellular vessels recellularize and evolve into living blood vessels after human implantation," the reference value for suture strength of HAVs was reported incorrectly within the Results section. The PDF and HT ...
Full textCite
Journal ArticleJ Surg Res · January 2018
BACKGROUND: Synthetic expanded polytetrafluorethylene (ePTFE) grafts are routinely used for vascular repair and reconstruction but prone to sustained bacterial infections. Investigational bioengineered human acellular vessels (HAVs) have shown clinical suc ...
Full textLink to itemCite
Journal ArticleEuropean journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery · October 2017
BackgroundArteriovenous fistulae are the currently recommended gold standard vascular access modality for haemodialysis because of their prolonged patency, improved durability, and low risk of infection for those that mature. However, notable disa ...
Full textCite
Journal ArticleJ Cardiovasc Transl Res · October 2011
Intimal hyperplasia is one of the prominent failure mechanisms for arteriovenous fistulas and arteriovenous access grafts. Human tissue-engineered vascular grafts (TEVGs) were implanted as arteriovenous grafts in a novel baboon model. Ultrasound was used t ...
Full textLink to itemCite
Journal ArticleSci Transl Med · February 2, 2011
Autologous or synthetic vascular grafts are used routinely for providing access in hemodialysis or for arterial bypass in patients with cardiovascular disease. However, some patients either lack suitable autologous tissue or cannot receive synthetic grafts ...
Full textLink to itemCite
Journal ArticleAnn Biomed Eng · November 2008
Mechanical models have potential to guide the development and use of engineered blood vessels as well as other engineered tissues. This paper presents a microstructurally motivated, pseudoelastic, mechanical model of the biaxial mechanics of engineered ves ...
Full textLink to itemCite
Journal ArticleAnn Biomed Eng · October 2007
Collagen is the structural molecule that is most correlated with strength in blood vessels. In this study, we compared the properties of collagen in engineered and native blood vessels. Transmission electron microscopy (TEM) was used to image sections of e ...
Full textLink to itemCite
Journal ArticleAnn Biomed Eng · March 2007
With the goal of mimicking the mechanical properties of a given native tissue, tissue engineers seek to culture replacement tissues with compositions similar to those of native tissues. In this report, differences between the mechanical properties of engin ...
Full textLink to itemCite
Journal ArticleTissue Eng · February 2006
It is well established that, in multicellular systems, conventional cryopreservation results in damaging ice formation, both in the cells and in the surrounding extracellular matrix. As an alternative to conventional cryopreservation, we performed a feasib ...
Full textLink to itemCite
Journal ArticleCell Transplant · July 2005
In many cases, the mechanical strengths of tissue-engineered arteries do not match the mechanical strengths of native arteries. Ultimate arterial strength is primarily dictated by collagen in the extracellular matrix, but collagen in engineered arteries is ...
Full textLink to itemCite
Journal ArticleLancet · June 18, 2005
Tissue engineering has made considerable progress in the past decade, but advances have stopped short of clinical application for most tissues. We postulated that an obstacle in engineering human tissues is the limited replicative capacity of adult somatic ...
Full textLink to itemCite
Journal ArticleCell Transplant · 2005
In many cases, the mechanical strengths of tissue-engineered arteries do not match the mechanical strengths of native arteries. Ultimate arterial strength is primarily dictated by collagen in the extracellular matrix. but collagen in engineered arteries is ...
Link to itemCite
Journal ArticleCell Transplant · September 2003
More than 570,000 coronary artery bypass grafts are implanted each year, creating an important demand for small-diameter vascular grafts. For patients who lack adequate internal mammary artery or saphenous vein, tissue-engineered arteries may prove useful. ...
Full textLink to itemCite
Journal ArticleCell Transplant · 2003
More than 570,000 coronary artery bypass grafts are implanted each year, creating an important demand for small-diameter vascular grafts. For patients who lack adequate internal mammary artery or saphenous vein, tissue-engineered arteries may prove useful. ...
Link to itemCite